Liu X - Search Results

1

Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells.

Xia S, Liu Z, Cai J, Ren H, Li Q, Zhang H, Yue J, Zhou Q, Zhou T, Wang L, Liu X, Zhou X. Xia S, et al. Among authors: liu z, liu x. J Control Release. 2023 Mar;355:54-67. doi: 10.1016/j.jconrel.2023.01.052. Epub 2023 Feb 2. J Control Release. 2023. PMID: 36693527

2

A tumor-targeting MRI contrast agent based on hypoxia and pH-responsive nanogel.

Wang T, Zeng Q, Tang J, Sui M, Liu X, Shen Y. Wang T, et al. Among authors: liu x. J Control Release. 2015 Sep 10;213:e104-5. doi: 10.1016/j.jconrel.2015.05.175. Epub 2015 Aug 19. J Control Release. 2015. PMID: 27005031 No abstract available.

3

In vitro inhibition of cancer stem cells by biguanidine-based macromolecular drug.

Ye M, Tang J, Sui M, Liu X, Shen Y. Ye M, et al. Among authors: liu x. J Control Release. 2015 Sep 10;213:e79. doi: 10.1016/j.jconrel.2015.05.131. Epub 2015 Aug 19. J Control Release. 2015. PMID: 27005230 No abstract available.

4

Jumping the nuclear envelop barrier: Improving polyplex-mediated gene transfection efficiency by a selective CDK1 inhibitor RO-3306.

Zhou X, Liu X, Zhao B, Liu X, Zhu D, Qiu N, Zhou Q, Piao Y, Zhou Z, Tang J, Shen Y. Zhou X, et al. Among authors: liu x. J Control Release. 2016 Jul 28;234:90-7. doi: 10.1016/j.jconrel.2016.05.042. Epub 2016 May 17. J Control Release. 2016. PMID: 27212103

5

Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration.

Zhou Z, Liu X, Zhu D, Wang Y, Zhang Z, Zhou X, Qiu N, Chen X, Shen Y. Zhou Z, et al. Among authors: liu x. Adv Drug Deliv Rev. 2017 Jun 1;115:115-154. doi: 10.1016/j.addr.2017.07.021. Epub 2017 Aug 1. Adv Drug Deliv Rev. 2017. PMID: 28778715 Review.

6

Terminating the criminal collaboration in pancreatic cancer: Nanoparticle-based synergistic therapy for overcoming fibroblast-induced drug resistance.

Wang L, Liu X, Zhou Q, Sui M, Lu Z, Zhou Z, Tang J, Miao Y, Zheng M, Wang W, Shen Y. Wang L, et al. Among authors: liu x. Biomaterials. 2017 Nov;144:105-118. doi: 10.1016/j.biomaterials.2017.08.002. Epub 2017 Aug 2. Biomaterials. 2017. PMID: 28837958

7

GDC-0449 improves the antitumor activity of nano-doxorubicin in pancreatic cancer in a fibroblast-enriched microenvironment.

Zhou Q, Zhou Y, Liu X, Shen Y. Zhou Q, et al. Among authors: liu x. Sci Rep. 2017 Oct 17;7(1):13379. doi: 10.1038/s41598-017-13869-0. Sci Rep. 2017. PMID: 29042665 Free PMC article.

8

Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.

Xiang J, Wu B, Zhou Z, Hu S, Piao Y, Zhou Q, Wang G, Tang J, Liu X, Shen Y. Xiang J, et al. Among authors: liu x. Sci China Life Sci. 2018 Apr;61(4):436-447. doi: 10.1007/s11427-017-9274-9. Epub 2018 Mar 19. Sci China Life Sci. 2018. PMID: 29572777

9

New path to treating pancreatic cancer: TRAIL gene delivery targeting the fibroblast-enriched tumor microenvironment.

Jiang H, Wang S, Zhou X, Wang L, Ye L, Zhou Z, Tang J, Liu X, Teng L, Shen Y. Jiang H, et al. Among authors: liu x. J Control Release. 2018 Sep 28;286:254-263. doi: 10.1016/j.jconrel.2018.07.047. Epub 2018 Jul 31. J Control Release. 2018. PMID: 30075209

10

SAHA (vorinostat) facilitates functional polymer-based gene transfection via upregulation of ROS and synergizes with TRAIL gene delivery for cancer therapy.

Zhou X, Liu Z, Wang H, Liu X, Zhou Z, Tang J, Liu X, Zheng M, Shen Y. Zhou X, et al. Among authors: liu z, liu x. J Drug Target. 2019 Mar;27(3):306-314. doi: 10.1080/1061186X.2018.1519028. Epub 2018 Sep 25. J Drug Target. 2019. PMID: 30188217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137,858 results

Search Page

Filters